Percutaneous Left Atrial Appendage Closure Is a Reasonable Option for Patients With Atrial Fibrillation at High Risk for Cerebrovascular Events [New Techniques]
Conclusions—
This nationwide prospective registry shows that, in the French population, LAA closure is mainly used in patients with high comorbidity rates and a poor prognosis. LAA closure in such patients seems reasonable to decrease the stroke rate. The overall health status of these patients should be taken into account during the preprocedural evaluation process.
Clinical Trial Registration—
URL: https://www.clinicaltrials.gov. Unique identifier: NCT02252861.
Source: Circulation: Cardiovascular Interventions - Category: Cardiology Authors: Teiger, E., Thambo, J.-B., Defaye, P., Hermida, J.-S., Abbey, S., Klug, D., Juliard, J.-M., Pasquie, J.-L., Rioufol, G., Lepillier, A., Elbaz, M., Horvilleur, J., Brenot, P., Pierre, B., Le Corvoisier, P., on behalf of the French National Left Atrial Appe Tags: Arrhythmias, Treatment, Ischemic Stroke New Techniques Source Type: research
More News: Arrhythmia | Atrial Fibrillation | Bleeding | Cardiology | Cardiovascular | Clinical Trials | France Health | Heart | Hemorrhagic Stroke | Ischemic Stroke | Stroke